Inventor

MITTENDORF JOACHIM

DE39 patents

⚠️ This page may combine multiple inventors who share the name “MITTENDORF JOACHIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MITTENDORF JOACHIM

BAYER AG

Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

Use of known agonists of the central cannabinoid receptor CB1

Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

Tolerability of pharmaceutically active β-amino acids

Aryl sulphonamide amino acid esters and analogues

Aryl sulphonamides and analogues

Cyclopentane- and -pentene-β-amino acids

Cyclopentane- and -pentene-β-amino acids

Use of known agonists of the central cannabinoid receptor CB1

Efficient and highly enantioselective process for the preparation of enantiomerically pure cyclopentane-β-amino acids

Method of preserving materials using 4-methylene-2-amino-cyclopentane-1-carboxylic acids

1,3,2-benzodithiazol-1-oxides as microbiocides

Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation

Antimycotic carbonyl- and amino-substituted tetrahydrofurans

High enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-(β)-amino acids

Arylsulphonamides and analogues

Cyclopentane-β-amino acid tripeptides

Substituted amidoalkyl-uracils and their use

Pyrrolidine compounds and process of preparing

Highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives

Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives

Pyrrolidine compounds and process of preparing

SCHIROK HARTMUT

Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders

Aliphatically substituted pyrazolopyridines, and the use thereof

Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase

Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors

ADVERIO PHARMA GMBH

Substituted 5-flouro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Bayer Pharma AG

5-aminotetrahydroquinoline-2-carboxylic acids and their use

5-aminotetrahydroquinoline-2-carboxylic acids and their use

5-aminotetrahydroquinoline-2-carboxylic acids and their use

FOLLMANN MARKUS

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof

BAYER IP GMBH

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

BAYER SCHERING PHARMA AG

Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors

Substituted phenylamino-pyrimidines